Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06257082 · ClinicalTrials.gov registry record · NA
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
A NA study of Diabetic Retinopathy, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 1,526
- Enrollment target
- 1
- Study location
NCT06257082: Recruiting NA study of Diabetic Retinopathy, sponsored by University of Wisconsin, Madison.
NCT06257082 is a NA study of Diabetic Retinopathy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 1,526 participants, roughly in line with the 1,650-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06257082, a NA study of Diabetic Retinopathy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,526 participants
- Enrollment target
- 1
- Study location
Study Summary
An online survey (n=1,500) and 4 focus groups will be conducted with Latinx patients with diabetes (n=20) to obtain preliminary data regarding whether and how patient and clinician video testimonial interventions (n=6) increase eye health literacy and trust in healthcare.
Primary Outcome
CADEES is scored from 1-5 where higher scores indicate increase eye health literacy.
Conditions Studied
Interventions
- OTHER Online Survey
Study Locations (1)
Wisconsin
- UW Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,526 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT06257082 shows while recruiting
NCT06257082 is an interventional study that assigns participants to a tested intervention. Its 1,526 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,650-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target.
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which Online Survey is the first listed.
NCT06257082 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06257082 about?
NCT06257082 is a clinical study titled "Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities". An online survey (n=1,500) and 4 focus groups will be conducted with Latinx patients with diabetes (n=20) to obtain preliminary data regarding whether and how patient and clinician video testimonial interventions (n=6) increase eye health literacy and trust in healthcare.
What is the current status of trial NCT06257082?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,526 participants. The study started on 2025-05-21. Estimated completion is 2026-05.
What conditions does trial NCT06257082 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
What interventions are being tested in trial NCT06257082?
The interventions under investigation include: Online Survey (OTHER).
Who is sponsoring clinical trial NCT06257082?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06257082 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06257082's enrollment target sits among peer trials
1,526 5th of 57 higher than 53 of 57 other Diabetic Retinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Retinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Implementation of Teleophthalmology in Urban Health Systems Study
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
-
Circadian Amplification in Diabetic Retinopathy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06623097 · 1,528 participants · NA
Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
- NCT06876714 · 1,524 participants · Phase 3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- NCT06393374 · 1,530 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- NCT07114510 · 1,530 participants · NA
Optimal Ventilation for Cardiac Arrest
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI